Menu

New Zika Transmission Zone Near Miami

The US Centers for Disease Control and Prevention identifies a 1-square-mile area near Miami where Zika virus appears to be spreading.

Oct 14, 2016
Ben Andrew Henry

WIKIPEDIA, JAMES GATHANY

The US Centers for Disease Control and Prevention (CDC) on Thursday (October 13) announced that Zika virus has been found actively spreading in an area near Miami, where health officials confirmed five new cases of infection.

Weeks earlier, the nearby Wynwood neighborhood was cleared of the virus, but a section of Miami Beach remains an area of active transmission. The CDC reiterated its advice that pregnant women consider avoiding travel to Miami-Dade County.

The newly identified zone occupies about one square mile to the north of Miami. Three of the new cases are in individuals who live in the area, while the other two individuals work or visit the area. Around 1,020 Zika cases have been identified in Florida, STAT News reported, but the majority of those cases are in individuals who caught the virus travelling outside the country. 

The onset of cooler weather should help lower the risk of mosquito-borne transmission, but “we’re not yet at the end of mosquito season, so we might continue to see local transmission going on for a little while yet,” Tom Skinner, a spokesperson for the CDC, told STAT News.

“We have seen that aggressive mosquito control efforts have worked in areas like Wynwood and we hope the county also aggressively sprays in this area,” Florida Governer Rick Scott said in a statement.

Scott stressed the need to mobilize government resources for keeping Zika under control. “It has been two weeks since federal funding to fight Zika was approved by Congress and signed by President Obama. However, Florida has not yet received a dime. We don’t need bureaucratic timelines—we need funding now.” 

See “Congress Approves $1.1 Billion for Zika

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.